The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy
about
The innate immune response to coxsackievirus B3 predicts progression to cardiovascular disease and heart failure in male miceRegulation of cardiac gene expression by KLF15, a repressor of myocardin activitySignaling effectors underlying pathologic growth and remodeling of the heartThe case for inhibiting p38 mitogen-activated protein kinase in heart failureComplete inhibition of anisomycin and UV radiation but not cytokine induced JNK and p38 activation by an aryl-substituted dihydropyrrolopyrazole quinoline and mixed lineage kinase 7 small interfering RNAEndothelial deletion of murine Jag1 leads to valve calcification and congenital heart defects associated with Alagille syndromeMitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.Cardiomyocyte-Specific Human Bcl2-Associated Anthanogene 3 P209L Expression Induces Mitochondrial Fragmentation, Bcl2-Associated Anthanogene 3 Haploinsufficiency, and Activates p38 SignalingA-kinase anchoring protein Lbc coordinates a p38 activating signaling complex controlling compensatory cardiac hypertrophyKey roles of endothelin-1 and p38 MAPK in the regulation of atrial stretch responseRecovery of skeletal muscle mass after extensive injury: positive effects of increased contractile activityActivation of ASK1, downstream MAPKK and MAPK isoforms during cardiac ischaemiaOverexpression of bone morphogenetic protein 10 in myocardium disrupts cardiac postnatal hypertrophic growthp38 MAP kinases in the heartActivation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy.The AP-1 transcription factor c-Jun prevents stress-imposed maladaptive remodeling of the heart.Active kinase proteome screening reveals novel signal complexity in cardiomyopathy.Myocardial survival signaling in response to stem cell transplantation.Phosphorylation-dependent degradation of p300 by doxorubicin-activated p38 mitogen-activated protein kinase in cardiac cells.Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load.L-Carnitine rescues ketamine-induced attenuated heart rate and MAPK (ERK) activity in zebrafish embryos.Pathway analysis of dilated cardiomyopathy using global proteomic profiling and enrichment maps.Myocardial adenosine A(1)-receptor-mediated adenoprotection involves phospholipase C, PKC-epsilon, and p38 MAPK, but not HSP27MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart.Aldosterone modulates cell proliferation and apoptosis in the neonatal rat heartThe p38 mitogen-activated protein kinase pathway--a potential target for intervention in infarction, hypertrophy, and heart failure.Acetylation of a conserved lysine residue in the ATP binding pocket of p38 augments its kinase activity during hypertrophy of cardiomyocytesThe role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis.Atrial chamber-specific expression of sarcolipin is regulated during development and hypertrophic remodeling.Augmented cardiac hypertrophy in response to pressure overload in mice lacking ELTD1.Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectivesp38alpha mitogen-activated protein kinase plays a critical role in cardiomyocyte survival but not in cardiac hypertrophic growth in response to pressure overload.p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes.p38 mitogen-activated protein kinase mediates the Fas-induced mitochondrial death pathway in CD8+ T cells.Angiotensin II-induced cardiovascular load regulates cardiac remodeling and related gene expression in late-gestation fetal sheep.Transfusion effects on cardiomyocyte growth and proliferation in fetal sheep after chronic anemiap38α regulates SERCA2a function.RhoA signaling in cardiomyocytes protects against stress-induced heart failure but facilitates cardiac fibrosis.The effect of adrenalectomy on the cardiac response to subacute fetal anemia.
P2860
Q21195890-031AEA97-9AB2-48AE-BC30-89697620591BQ24620992-37810706-7E30-4D2F-B784-A1B832C5FFC0Q26825154-34359F88-AA79-4671-80B8-3FC9114EED06Q28080674-9028EC44-BA90-4592-B941-D274F8F3D0F6Q28237359-3AB08F7D-EDCF-4335-84D1-9B169FF6AEE8Q28277874-5C11B081-1B84-4DAC-887F-25C0A4FC597EQ28296128-9BB2C28B-218E-4941-A3A0-43D3E9204504Q28385823-D2546308-ADA6-4779-930D-3CC1C09793A9Q28570967-991465A2-8066-4569-8B96-624C7470FBD2Q28577467-283A9B1E-D330-4D3D-896E-19ADB247EE9CQ28579697-BC525434-DD86-4F37-8268-1AE94E34BC75Q28584161-EDD39DC7-64BB-41DF-9947-B598BEE6BA10Q28589677-9EA935D5-5312-49D2-9B6A-57C191C4E080Q28603117-0E3285D0-CE7A-4E6C-B7AA-5E926EDC1519Q30498939-89511C66-E71C-4C4C-B477-CAD18115AE02Q31138518-B24997FC-2565-4244-984A-CF7A209873DEQ31148687-529E5482-1AAA-47DF-8FE4-F36A2E2F6DD2Q33635730-741F70F2-F011-4C03-A806-A1495B04AE62Q33707676-8C4293A1-911C-49D5-AB11-B3E16D9AB807Q33713890-76750242-62DE-4230-880F-C0DDEBEAF3E0Q33743649-33340B88-B283-4584-8BB2-E16EDE8C0347Q33796903-32E65D0C-A453-4D1F-8F94-256F5E27D3B7Q33887660-2D6BF267-8B26-44C1-9037-439B4E367943Q33917079-14A8F10F-562F-4088-921A-A0B364631A70Q33991447-2A37C856-184F-4023-A7A0-9A9591897A0BQ34073747-F4B7FFF2-5D68-4688-B9A8-7F5D87EE6276Q34148893-113D82C6-08EE-4272-A689-F7370800BFE6Q34173928-F773F12F-42DB-4F86-9A23-49D3065B9D34Q34183974-87657C75-868B-4842-AEDE-C33524D394BBQ34184625-6FA6E29A-44B4-4B29-B58C-546BA32C048DQ34273479-E4F93AC2-BA8E-40D3-8781-63A26AD3EDA5Q34289211-BA9DE50C-225D-47C9-A367-BDFA3F3F8B71Q34372422-8A1FE38C-2B94-4B5B-9A1F-5140BEF005BCQ34415888-ECEAD4C0-A30C-49F9-A4D3-9D9F1531C7C8Q34519958-5D26833D-B095-4577-B67A-07ACEA6301D1Q34609798-349CCB5D-9EB6-49EF-A45F-872A0D2C5567Q34959420-6322F6E9-DBD5-46BC-BB3A-4EAB5D633A07Q34976170-32DC7551-D45F-469F-9119-0DEBDEF0C26DQ34989031-0D6ED58F-C80F-442E-BB36-4B64FCB0D466Q34992234-21E9C270-EFD3-4A20-96FD-BF21786303B6
P2860
The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy
description
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
article publié dans les Procee ...... f the United States of America
@fr
artículu científicu espublizáu en 2001
@ast
im Oktober 2001 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2001/10/09)
@sk
vědecký článek publikovaný v roce 2001
@cs
wetenschappelijk artikel (gepubliceerd op 2001/10/09)
@nl
наукова стаття, опублікована в жовтні 2001
@uk
name
The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy
@ast
The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy
@en
The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy
@nl
type
label
The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy
@ast
The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy
@en
The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy
@nl
prefLabel
The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy
@ast
The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy
@en
The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy
@nl
P2093
P2860
P921
P3181
P356
P1476
The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy
@en
P2093
D. A. Kass
D. Georgakopoulos
J. Saffitz
R. P. Xiao
P2860
P304
12283–12288
P3181
P356
10.1073/PNAS.211086598
P407
P50
P577
2001-10-09T00:00:00Z